Prostate Cancer
Prostate Cancer
Advertisement
Katie KoskoSUO 2024 | December 19, 2024
Less than half of VA hospitals are sites for prostate cancer clinical trials.
Read More
Katie KoskoSUO 2024 | December 5, 2024
Prostate-specific antigen (PSA) velocity and PSA values taken together may improve the specificity of monitoring.
Katie KoskoSUO 2024 | December 5, 2024
Patients and survivors who engaged in physical activity experienced a protective effect on mental health.
Katie KoskoSUO 2024 | December 4, 2024
Contaminants, such as heavy metals, pesticides, and microbial pathogens, may influence cancer severity.
Katie KoskoSUO 2024 | December 4, 2024
Patients and caregivers most valued the role of genetics in understanding risk stratification.
Katie KoskoSUO 2024 | December 2, 2024
The rate of prostate cancer mortality is higher in parts of the United States where structural racism is also higher.
Katie KoskoSUO 2024 | December 2, 2024
The slower recovery PSA screening rate in Black men highlights the persistent racial disparities in health care access.
Katie KoskoSUO 2024 | November 27, 2024
In this analysis, the model performed best for predicting survival Asian patients and worst for Non-Hispanic Black patients.
Katie KoskoSUO 2024 | November 26, 2024
Hispanic men who are Black or Cuban had the lowest rates of prostate-specific antigen screening.
Katie KoskoSUO 2024 | November 26, 2024
Race-associated tumor differences can affect early diagnostic testing and targeted therapeutics.
Katie KoskoSUO 2024 | November 25, 2024
Only half of patients received timely follow-up, and 34% received no follow-up at all.
Tamara ThomasProstate Cancer | November 19, 2024
transgender status was not a predictor of prostate cancer-related death.
Rebecca AraujoASTRO 2024 | December 6, 2024
These findings highlight the importance of racial diversity in genomic profiling and clinical trials.
Rebecca AraujoASTRO 2024 | October 22, 2024
Men aged 60-69 years had a decreased risk of death with the addition of androgen deprivation therapy.
Rebecca AraujoASTRO 2024 | October 21, 2024
The adoption of polyethylene glycol hydrogel spacer use in prostate cancer care has been slower in Black patients.
Rebecca AraujoASTRO 2024 | October 15, 2024
Guideline-concordant androgen deprivation therapy is associated with a survival benefit in high-risk prostate cancer.
Rebecca AraujoASTRO 2024 | October 14, 2024
Patients who underwent radical prostatectomy also had a higher likelihood of decision regret.
Tamara ThomasASTRO 2024 | October 17, 2024
Both Fluciclovine and PSMA PET/CT guided radiation therapy would significantly change pre-PET radiation therapy volumes.
Tamara ThomasASTRO 2024 | October 10, 2024
P-CARE integrates genetics, family history, and ancestry to offer a more objective risk assessment.
Tamara ThomasASTRO 2024 | October 17, 2024
After 10 years, 3.3% of patients who were recurrence-free developed distant metastasis.
Advertisement
Advertisement
Advertisement
Latest News

December 27, 2024